Omada Health, Inc.
Omada Health, Inc. is listed today as Omada Health, Inc.: market value, financials and filings are on its company page.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
As the listed company Omada Health, Inc., its revenue in fiscal 2025 came from these product and service lines: Hardware $19.17 million (7%).
Annual report (SEC XBRL) · Dec 2025
Omada Health, Inc. chose not to state its revenue in its newest notice of a funding round (Oct 2015).
SEC Form D · Oct 2015
The industry group it chose in its notices: Other Health Care.
SEC Form D · Oct 2015
Products and services#
No products or services of Omada Health, Inc. are on record.
Investors#
9 named in official filings. Open an investor to see everything it has backed.
| Investor | Kind | Amount | Round | Role | Source |
|---|---|---|---|---|---|
| Revelation Alpine GP, LLC | Other | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Revelation Alpine, LLC | Other | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Revelation Alpine, L.P. | Fund or asset manager | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Revelation Healthcare Fund II GP, LLC | Fund or asset manager | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Revelation Healthcare Fund II GP, L.P. | Fund or asset manager | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Revelation Healthcare Fund II, L.P. | Fund or asset manager | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Revelation Healthcare Fund IV GP, LLC | Fund or asset manager | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Revelation Healthcare Fund IV GP, L.P. | Fund or asset manager | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
| Revelation Healthcare Fund IV, L.P. | Fund or asset manager | not stated | not stated | Held Series C, C-1, D and E preferred stock, 10% owner (Form 3, 2025) | SEC Form 3 |
Largest shareholders today
Institutions holding Omada Health, Inc. shares, as of Sep 30, 2026.
- Divisadero Street Capital Management, LP$90 M6.96%
- BlackRock, Inc.$78 M6.06%
- American Century Companies Inc$77 M5.96%
- Cigna Investments Inc /new$72 M5.55%
- Morgan Stanley$67 M5.22%
- D. E. Shaw & Co., Inc.$62 M4.78%
- FMR LLC$58 M4.50%
- Vanguard Capital Management LLC$51 M3.96%
- Loomis Sayles & Co L P$34 M2.62%
- Millennium Management LLC$29 M2.27%
- Estuary Capital Management LP$28 M2.16%
- Acadian Asset Management LLC$26 M2.02%
- Geode Capital Management, LLC$26 M1.99%
- State Street Corp$26 M1.98%
- Oberweis Asset Management Inc/$25 M1.96%
As of Sep 30, 2026
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Adrian James | Executive officer | Oct 2015 |
| Andrew DiMichelle | Executive officer | Oct 2015 |
| Sean Duffy | Executive officer | Oct 2015 |
| Adrian James | Director | Oct 2015 |
| Andrew DiMichelle | Director | Oct 2015 |
| Balaji Srinivasan | Director | Oct 2015 |
| Casper De Clercq | Director | Oct 2015 |
| Jonathan Root | Director | Oct 2015 |
| Sean Duffy | Director | Oct 2015 |
| Tony Chou | Director | Jun 2014 |
Went public since 2025. Its SEC number is that of a company listed on a stock exchange.